Test Details: Kanamycin is part of a group of medicines called injectables discovered in 1957. It is used as part of a treatment regimen, usually involving 5 medicines, to treat MDR TB. Kanamycin is administered via injection for at least six months during the intensive phase of treatment. When necessary, it may be continued during the continuation phase, administering the same dose 2 to 3 times weekly.